Events

Resilience is critical in biomanufacturing, especially in an increasingly connected global ecosystem where economic shifts in one region can threaten operations everywhere. Join Bioprocess Online’s chief editor, Tyler Menichiello, for an interactive panel discussion on how companies are navigating a tight funding environment, raw material shortages, and global market pressures. The panel will feature Adam...

We’re still striving to deliver mRNA-LNPs to cells/tissue types that go beyond the liver. Outside of exploring different lipid combinations to expand mRNA-LNPs’ deliverability to new tissues, this discussion will investigate the industry’s push toward active delivery to improve targeting, as well as other advancements being made to improve LNP development, quality, & deliverability. Registration...

We are very excited to announce our indoor Biotech Community Lunch Event at the Atrium. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. All the biotech tenants at 100-700 Technology Square and other companies in the Cambridge vicinity are...

As artificial intelligence (AI) and digital tools rapidly evolve, they are poised to reshape biopharmaceutical cell line development and subsequent manufacturing, overcoming inefficiencies in expression, scalability, and production. The webinar will discuss how the Cytiva™ cell culture media platform and Asimov’s CHO Edge system routinely deliver high-titer clones (8–11 g/L) in 14 weeks for monoclonal...

Join Cell & Gene’s Chief Editor, Erin Harris, for this timely Cell & Gene Live offering an in-depth regulatory outlook with two of the field’s most trusted experts, Wilson Bryan, M.D., former director of FDA’s Office of Tissues and Advanced Therapies (OTAT), and Daniela Drago, Ph.D., RAC, Partner at NDA Partners. Drawing on his tenure...

Hear directly from leading CDMOs about their current fill/finish capabilities, facility locations, and timelines. Through short, interactive presentations, you’ll gain insight into available capacity across sterile filling, lyophilization, and advanced packaging—all with the opportunity to ask live questions.

Developing robust cell harvest and media exchange processes is often complex, particularly when moving from development to GMP manufacturing. Differences in equipment, scale, and automation can introduce variability and delay clinical timelines. Common methods such as TFF face challenges in maintaining consistent parameters during scale-up, while disc-stack centrifugation lacks scale-down models and can expose cells...

Study design is increasingly empowered by a rich and diverse array of data. New sources continue to emerge, fueled by advances in AI that enable the integration of information from literature, ClinicalTrials.gov, digitized protocols, and beyond. Harnessing these complementary data streams allows researchers to design studies that are not only operationally efficient but also more...